Copyright
©The Author(s) 2018.
World J Gastroenterol. Jan 14, 2018; 24(2): 266-273
Published online Jan 14, 2018. doi: 10.3748/wjg.v24.i2.266
Published online Jan 14, 2018. doi: 10.3748/wjg.v24.i2.266
Variable | AFP ≥ 160 ng/mL | AFP < 160 ng/mL | P value |
Overall ORR | |||
PR | 14 (30.4) | 28 (68.3) | < 0.001a |
SD + PD | 32 (69.6) | 13 (31.7) | |
ORR to doublet regimens | |||
PR | 10 (26.3) | 26 (70.3) | < 0.001a |
SD + PD | 28 (73.7) | 11 (30.7) | |
ORR to triplet regimens | |||
PR | 4 (57.1) | 2 (50.0) | 0.652 |
SD + PD | 3 (42.9) | 2 (50.0) | |
Liver metastasis rate | 69.8% | 50.0% | 0.030a |
Median OS | 13.0 mo | 14.8 mo | 0.712 |
- Citation: Wang YK, Shen L, Jiao X, Zhang XT. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP. World J Gastroenterol 2018; 24(2): 266-273
- URL: https://www.wjgnet.com/1007-9327/full/v24/i2/266.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i2.266